FDA
- Status: approved
Disitamab Vedotin and Gemcitabine (Disitamab Vedotin and Gemcitabine) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Chunguang yang (101937) is the originator. The local marketing authorisation holder may differ — check the official source linked above.